These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32372504)

  • 1. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
    Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
    Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
    Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
    Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
    Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
    Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
    Jann JC; Mossner M; Riabov V; Altrock E; Schmitt N; Flach J; Xu Q; Nowak V; Obländer J; Palme I; Weimer N; Streuer A; Jawhar A; Darwich A; Jawhar M; Metzgeroth G; Nolte F; Hofmann WK; Nowak D
    Nat Commun; 2021 Oct; 12(1):6170. PubMed ID: 34697318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow from periacetabular osteotomies as a novel source for human mesenchymal stromal cells.
    Handke M; Rakow A; Singer D; Miebach L; Schulze F; Bekeschus S; Schoon J; Wassilew GI
    Stem Cell Res Ther; 2023 Nov; 14(1):315. PubMed ID: 37924114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
    Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
    Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.
    Sarhan D; Wang J; Sunil Arvindam U; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32045384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.
    Roversi FM; Lopes MR; Machado-Neto JA; Longhini AL; Duarte Ada S; Baratti MO; Palodetto B; Corrocher FA; Pericole FV; Campos Pde M; Favaro P; Traina F; Saad ST
    Stem Cells Dev; 2014 May; 23(10):1109-20. PubMed ID: 24410667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
    Battula VL; Chen Y; Cabreira Mda G; Ruvolo V; Wang Z; Ma W; Konoplev S; Shpall E; Lyons K; Strunk D; Bueso-Ramos C; Davis RE; Konopleva M; Andreeff M
    Blood; 2013 Jul; 122(3):357-66. PubMed ID: 23741006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.
    Fei CM; Guo J; Zhao YS; Zhao SD; Zhen QQ; Shi L; Li X; Chang CK
    J Transl Med; 2018 Aug; 16(1):234. PubMed ID: 30143008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
    Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
    Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
    Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.
    Kim J; Denu RA; Dollar BA; Escalante LE; Kuether JP; Callander NS; Asimakopoulos F; Hematti P
    Br J Haematol; 2012 Aug; 158(3):336-46. PubMed ID: 22583117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.
    Mognetti B; La Montagna G; Perrelli MG; Pagliaro P; Penna C
    J Cell Mol Med; 2013 Feb; 17(2):287-92. PubMed ID: 23301946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.